The demand for N-heptane in EU is projected to grow from USD 174.3 million in 2025 to USD 289.4 million by 2035, at a CAGR of 5.2%. 99% Purity will dominate with a 46.0% market share, while pharmaceuticals will lead the application (end use) segment with a 33.0% share.